BARCLAYS PLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 65 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$66
-52.2%
17,777
-13.1%
0.00%
Q2 2023$138
-40.5%
20,460
-42.8%
0.00%
Q1 2023$232
+31.1%
35,782
+71.9%
0.00%
Q4 2022$177
-99.8%
20,810
+4.1%
0.00%
Q3 2022$106,000
+19.1%
19,985
-4.4%
0.00%
Q2 2022$89,000
+48.3%
20,897
+22.2%
0.00%
Q1 2022$60,00017,1050.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders